DRP classification | |
1. Non conformity to guidelines or contraindication | |
2. Untreated indication | |
3. Subtherapeutic dosage | |
4. Supratherapeutic dosage | |
5. Drug without indication | |
6. Drug interaction | |
7. Adverse drug reaction | |
8. Improper administration | |
9. Failure to receive drug | |
10. Drug monitoring | |
Pharmacist intervention classification | |
1. Addition of a new drug | |
2. Drug discontinuation | |
3. Drug switch | |
4. Change of administration route | |
5. Drug monitoring | |
6. Administration mode optimization | |
7. Dose adjustment | |
Potential impact classification | |
1. Extremely significant-information qualified by life and death situation. | |
2. Very significant-recommendation qualified by a potential or existing major organ dysfunction. | |
3. Significant-recommendation would bring care to a more acceptable and appropriate level (i.e., standard of practice). | |
4. Somewhat significant-benefit of the recommendation to the patient could be neutral depending on professional interpretation (to be differentiated from rank 3 where a standard of practice would support the recommendation). | |
5. No significance-recommendation is informational (not specifically related or meaningful to the patient in question.) | |
6. Adverse significance-recommendation supplied by the clinician may lead to adverse outcome. |